Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : The collaboration aims to develop iPSC-derived CAR-NK allogeneic cancer immunotherapies. Plasticell will use its combinatorial screening technology, CombiCult®, to develop optimal protocols to convert these iPSCs into natural killer (NK) cells for allog...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 25, 2023